2.0600
+0.0200
+(0.98%)
At close: January 10 at 3:29:01 PM GMT+1
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-68,793.8580
-68,793.8580
-42,973.3980
-56,674.5590
-54,253.2880
Investing Cash Flow
-150.7380
--
--
--
--
Financing Cash Flow
60,329.4140
60,329.4140
48,968.5680
59,594.0470
56,194.6260
End Cash Position
14,927.5380
14,927.5380
23,391.9820
17,396.8120
14,477.3240
Interest Paid Supplemental Data
475.0000
475.0000
1,160.0080
1,556.6910
46.2390
Issuance of Capital Stock
60,333.6810
60,333.6810
30,024.2130
62,307.3070
46,301.8410
Issuance of Debt
--
--
30,000.0000
10,000.0000
10,000.0000
Repayment of Debt
-4.2670
-4.2670
-10,231.7510
-12,319.1100
-3,692.5630
Free Cash Flow
-68,793.8580
-68,793.8580
-42,973.3980
-56,674.5590
-54,253.2880
9/30/2021 - 5/21/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SG7.MU Sage Therapeutics Inc
5.73
0.00%
6C1.SG CytomX Therapeutics Inc
0.8410
-9.52%
4A3.F Immatics N.V.
6.84
+1.71%
05Y.F Vivoryon Therapeutics N.V.
2.0200
+1.51%
BVNKF Bavarian Nordic A/S
26.25
0.00%
VVY.AS Vivoryon Therapeutics N.V.
1.9900
-1.49%
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
PHARM.AS Pharming Group N.V.
0.9105
-2.10%